Amedeo Smart

Free Medical Literature Service

 

Amedeo

Autoimmune Disorders
  Free Subscription

Articles published in
N Engl J Med
    April 2024
  1. MATHUR M, Barratt J, Suzuki Y
    Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. Reply.
    N Engl J Med. 2024;390:1245-1246.
    >> Share

  2. BELMONT HM
    Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
    N Engl J Med. 2024;390:1245.
    >> Share

  3. MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH
    Prevention of Cardiovascular Disease in Type 1 Diabetes.
    N Engl J Med. 2024;390:1207-1217.
    >> Share

    March 2024
  4. NETEA MG, van de Veerdonk FL
    Anti-Interleukin-23 Autoantibodies and Severe Infections.
    N Engl J Med. 2024;390:1143-1146.
    >> Share

  5. CHENG A, Kashyap A, Salvator H, Rosen LB, et al
    Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
    N Engl J Med. 2024;390:1105-1117.
    >> Share

  6. DRIVENES JL, Bygum A
    Spontaneous Oral Purpura in Immune Thrombocytopenia.
    N Engl J Med. 2024;390:1029.
    >> Share

  7. WECHSLER ME, Nair P, Terrier B, Walz B, et al
    Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2024;390:911-921.
    >> Share

    February 2024
  8. MULLER F, Taubmann J, Bucci L, Wilhelm A, et al
    CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
    N Engl J Med. 2024;390:687-700.
    >> Share

  9. ISAACS JD
    CAR T Cells - A New Horizon for Autoimmunity?
    N Engl J Med. 2024;390:758-759.
    >> Share

  10. HAUSER SL
    Silencing Immune Dialogue in Multiple Sclerosis.
    N Engl J Med. 2024;390:662-663.
    >> Share

  11. VERMERSCH P, Granziera C, Mao-Draayer Y, Cutter G, et al
    Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
    N Engl J Med. 2024;390:589-600.
    >> Share

    January 2024
  12. DANDONA P, Chaudhuri A, Ghanim H
    More on Semaglutide in Early Type 1 Diabetes. Reply.
    N Engl J Med. 2024;390:292.
    >> Share

  13. GAGLIA JL, Laffel LM, Patti ME
    More on Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2024;390:291.
    >> Share

  14. WEINRAUCH LA, D'Elia JA
    More on Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2024;390:291.
    >> Share

  15. DEVRIES JH
    More on Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2024;390:290.
    >> Share

  16. HADZIC N, Deheragoda M, Worth A, Bansal S, et al
    JAK Inhibition in STAT1 Gain-of-Function-Mediated Treatment-Resistant Autoimmune Hepatitis.
    N Engl J Med. 2024;390:284-286.
    >> Share

  17. LEE TTM, Bergford S, Murphy HR
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes. Reply.
    N Engl J Med. 2024;390:184.
    >> Share

  18. GRZYCH G, Kim I
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2024;390:183-184.
    >> Share

  19. VIVANTI AJ, Benachi A, Voican A
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2024;390:183.
    >> Share

  20. LEMLEY KV, Glassock RJ
    APRIL - Springtime for New IgA Nephropathy Therapy?
    N Engl J Med. 2024;390:80-81.
    >> Share

  21. LIU MJ, Li J
    Necrobiosis Lipoidica.
    N Engl J Med. 2024;390:70.
    >> Share

    December 2023
  22. ARJUNAN D, Bhadada SK
    Thyroid Dermopathy in Graves' Disease.
    N Engl J Med. 2023;389:2376.
    >> Share

  23. LUDVIGSSON J
    Immune Interventions at Onset of Type 1 Diabetes - Finally, a Bit of Hope.
    N Engl J Med. 2023;389:2199-2201.
    >> Share

  24. WAIBEL M, Wentworth JM, So M, Couper JJ, et al
    Baricitinib and beta-Cell Function in Patients with New-Onset Type 1 Diabetes.
    N Engl J Med. 2023;389:2140-2150.
    >> Share

    November 2023
  25. EL-ZAATARI ZM
    Anti-Glomerular Basement Membrane Glomerulonephritis.
    N Engl J Med. 2023;389:1901.
    >> Share

  26. BUSSEL JB, Hou M, Cines DB
    Primary Immune Thrombocytopenia in Pregnancy. Reply.
    N Engl J Med. 2023;389:1728.
    >> Share

  27. TRAN BW, May KA, Pal N
    Primary Immune Thrombocytopenia in Pregnancy.
    N Engl J Med. 2023;389:1728.
    >> Share

  28. MATHUR M, Barratt J, Chacko B, Chan TM, et al
    A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
    N Engl J Med. 2023 Nov 2. doi: 10.1056/NEJMoa2305635.
    >> Share

    October 2023
  29. RAMOS EL, Dayan CM, Chatenoud L, Sumnik Z, et al
    Teplizumab and beta-Cell Function in Newly Diagnosed Type 1 Diabetes.
    N Engl J Med. 2023 Oct 18. doi: 10.1056/NEJMoa2308743.
    >> Share

  30. LINDHOFF-LAST E, Schonborn L, Zaninetti C, Warkentin TE, et al
    Rescue Therapy in Chronic Prothrombotic Autoimmune Anti-PF4 Disorder.
    N Engl J Med. 2023;389:1339-1341.
    >> Share

  31. SPIERA RF, Unizony S, Warrington KJ, Sloane J, et al
    Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
    N Engl J Med. 2023;389:1263-1272.
    >> Share

  32. LEE TTM, Collett C, Bergford S, Hartnell S, et al
    Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2023 Oct 5. doi: 10.1056/NEJMoa2303911.
    >> Share

  33. GARG SK, Polsky S
    Technology Use and Glycemic Outcomes during Pregnancy with Type 1 Diabetes.
    N Engl J Med. 2023 Oct 5. doi: 10.1056/NEJMe2310798.
    >> Share

  34. ALETAHA D
    Polymyalgia Rheumatica - from Search for Efficacy to Choice of Strategy.
    N Engl J Med. 2023;389:1328-1329.
    >> Share

    September 2023
  35. BRODERICK L, Kastner DL
    Variant STAT4 and Treatment of an Autoinflammatory Syndrome. Reply.
    N Engl J Med. 2023;389:1151-1152.
    >> Share

  36. PASTORE S, De Martino E, Taddio A
    Variant STAT4 and Treatment of an Autoinflammatory Syndrome.
    N Engl J Med. 2023;389:1151.
    >> Share

  37. WANG WY, Cheng ST
    Sleeve Sign and Inverse Gottron's Papules in Anti-MDA5 Dermatomyositis.
    N Engl J Med. 2023;389:1032.
    >> Share

  38. DANDONA P, Chaudhuri A, Ghanim H
    Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2023;389:958-959.
    >> Share

    August 2023
  39. FUKUSHIMA H, Matsumoto M
    Cold Agglutinin Syndrome.
    N Engl J Med. 2023;389:642.
    >> Share

  40. BUSSEL JB, Hou M, Cines DB
    Management of Primary Immune Thrombocytopenia in Pregnancy.
    N Engl J Med. 2023;389:540-548.
    >> Share

  41. WARKENTIN TE, Baskin-Miller J, Raybould AL, Sheppard JI, et al
    Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies.
    N Engl J Med. 2023;389:574-577.
    >> Share

  42. KRISCHER JP, Lernmark A, Hagopian WA, Rewers MJ, et al
    SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens.
    N Engl J Med. 2023;389:474-475.
    >> Share

  43. KOOSHESH KA, Foy BH, Sykes DB, Gustafsson K, et al
    Health Consequences of Thymus Removal in Adults.
    N Engl J Med. 2023;389:406-417.
    >> Share

    June 2023
  44. WADWA RP, Beck RW, Breton MD
    Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes. Reply.
    N Engl J Med. 2023;388:2206-2207.
    >> Share

  45. SHIBUE K
    Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
    N Engl J Med. 2023;388:2206.
    >> Share

  46. HSU NC, Hsu CH
    Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
    N Engl J Med. 2023;388:2205-2206.
    >> Share

  47. LEE CD, Galetta SL, Dobson R
    Management of Possible Multiple Sclerosis.
    N Engl J Med. 2023;388:2195-2198.
    >> Share

    May 2023
  48. BAGHDASSARIAN H, Blackstone SA, Clay OS, Philips R, et al
    Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome.
    N Engl J Med. 2023 May 31. doi: 10.1056/NEJMoa2202318.
    >> Share

    April 2023
  49. CONNOLLY CM, Christopher-Stine L
    Periorbital Edema in Dermatomyositis.
    N Engl J Med. 2023;388:e52.
    >> Share

    March 2023
  50. BRUTTOMESSO D
    Technology in the Changing Management of Diabetes in Children.
    N Engl J Med. 2023;388:1052-1054.
    >> Share

  51. LEE AI, Heidari P, Fenves AZ, Bardia A, et al
    Case 8-2023: A 71-Year-Old Woman with Refractory Hemolytic Anemia.
    N Engl J Med. 2023;388:1032-1041.
    >> Share

  52. WADWA RP, Reed ZW, Buckingham BA, DeBoer MD, et al
    Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
    N Engl J Med. 2023;388:991-1001.
    >> Share

    January 2023
  53. RUSSELL SJ, Damiano ER, Calhoun P
    Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. Reply.
    N Engl J Med. 2023;388:380-382.
    >> Share

  54. KHOO TK
    Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2023;388:380.
    >> Share

  55. MURATA Y, Takita M, Kami M
    Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2023;388:380.
    >> Share

  56. AGGARWAL R, Charles-Schoeman C, Schessl J
    Trial of Intravenous Immune Globulin in Dermatomyositis. Reply.
    N Engl J Med. 2023;388:94-95.
    >> Share

  57. WERTH VP, Fiorentino DF, Vleugels RA
    Trial of Intravenous Immune Globulin in Dermatomyositis.
    N Engl J Med. 2023;388:94.
    >> Share

    November 2022
  58. BURNSIDE MJ, Williman JA, de Bock MI
    Open-Source Automated Insulin Delivery in Type 1 Diabetes. Reply.
    N Engl J Med. 2022;387:2007-2008.
    >> Share

  59. SCARAMUZZA AE, Cherubini V, Rabbone I
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:2006-2007.
    >> Share

  60. MURATA Y, Takita M, Kami M
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:2006.
    >> Share

  61. BRENNAN T
    Pharmaceutical Marketing Revisited - United States v. Biogen Idec.
    N Engl J Med. 2022;387:1631-1633.
    >> Share

    October 2022
  62. WERTH VP, Barbey C, Franchimont N
    Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus. Reply.
    N Engl J Med. 2022;387:1529.
    >> Share

  63. PSARRAS A, Vital EM
    Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus.
    N Engl J Med. 2022;387:1528-1529.
    >> Share

  64. REBELLO A, Joshi P
    Giant-Cell Arteritis.
    N Engl J Med. 2022;387:e36.
    >> Share

  65. AMATO AA
    Intravenous Immune Globulin Therapy in Dermatomyositis.
    N Engl J Med. 2022;387:1320-1321.
    >> Share

  66. AGGARWAL R, Charles-Schoeman C, Schessl J, Bata-Csorgo Z, et al
    Trial of Intravenous Immune Globulin in Dermatomyositis.
    N Engl J Med. 2022;387:1264-1278.
    >> Share

  67. LEELARATHNA L, Evans ML, Neupane S, Rayman G, et al
    Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes.
    N Engl J Med. 2022 Oct 5. doi: 10.1056/NEJMoa2205650.
    >> Share

    September 2022
  68. RUSSELL SJ, Beck RW, Damiano ER, El-Khatib FH, et al
    Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2022;387:1161-1172.
    >> Share

  69. COLIZZO FP, Shroff SG, High FA, Chen YB, et al
    Case 29-2022: A 33-Year-Old Man with Chronic Diarrhea and Autoimmune Enteropathy.
    N Engl J Med. 2022;387:1124-1134.
    >> Share

  70. HERRERA-COMOGLIO R, Lane S
    Vaccine-Induced Immune Thrombocytopenia and Thrombosis after the Sputnik V Vaccine.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2210813.
    >> Share

  71. FURIE RA, van Vollenhoven RF, Kalunian K, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
    N Engl J Med. 2022;387:894-904.
    >> Share

  72. BOLINDER J
    CLOuDs Disperse - Top-Notch Glucose Control and Residual C-Peptide Secretion.
    N Engl J Med. 2022;387:937-938.
    >> Share

  73. BOUGHTON CK, Allen JM, Ware J, Wilinska ME, et al
    Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes.
    N Engl J Med. 2022;387:882-893.
    >> Share

  74. BURNSIDE MJ, Lewis DM, Crocket HR, Meier RA, et al
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:869-881.
    >> Share

    August 2022
  75. STEINMAN L, Fox E, Hartung HP, Alvarez E, et al
    Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
    N Engl J Med. 2022;387:704-714.
    >> Share

  76. WINGERCHUK DM, Lucchinetti CF
    Neuromyelitis Optica Spectrum Disorder.
    N Engl J Med. 2022;387:631-639.
    >> Share

    July 2022
  77. WERTH VP, Furie RA, Romero-Diaz J, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
    N Engl J Med. 2022;387:321-331.
    >> Share

    June 2022
  78. KUTER DJ
    Rilzabrutinib in Immune Thrombocytopenia. Reply.
    N Engl J Med. 2022;386:2538.
    >> Share

  79. MURAKAMI J, Senoo Y, Tanimoto T
    Rilzabrutinib in Immune Thrombocytopenia.
    N Engl J Med. 2022;386:2537-2538.
    >> Share

  80. SCHONBORN L, Seck SE, Thiele T, Warkentin TE, et al
    SARS-CoV-2 Infection in Patients with a History of VITT.
    N Engl J Med. 2022 Jun 27. doi: 10.1056/NEJMc2206601.
    >> Share

  81. HUANG YM, Lin PH
    IgG4-Related Ophthalmic Disease.
    N Engl J Med. 2022;386:2315.
    >> Share

  82. JEBARAJ A, Lin A
    Sclerokeratitis in Granulomatosis with Polyangiitis.
    N Engl J Med. 2022;386:2221.
    >> Share

    April 2022
  83. WARE J, Hovorka R
    Closed-Loop Control in Very Young Children with Type 1 Diabetes. Reply.
    N Engl J Med. 2022;386:1482-1483.
    >> Share

  84. RING BL
    Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:1482.
    >> Share

  85. MURATA Y, Takita M, Kami M
    Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:1482.
    >> Share

  86. KUTER DJ, Efraim M, Mayer J, Trneny M, et al
    Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.
    N Engl J Med. 2022;386:1421-1431.
    >> Share

    March 2022
  87. SPERLING MA, Laffel LM
    Current Management of Glycemia in Children with Type 1 Diabetes Mellitus.
    N Engl J Med. 2022;386:1155-1164.
    >> Share

  88. COSTENBADER KH
    A New IMiD for Systemic Lupus Erythematosus - Tempering Our Excitement.
    N Engl J Med. 2022;386:1085-1086.
    >> Share

  89. MERRILL JT, Werth VP, Furie R, van Vollenhoven R, et al
    Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.
    N Engl J Med. 2022;386:1034-1045.
    >> Share

    January 2022
  90. YONG GY, Lim AL
    Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2022;386:374.
    >> Share

  91. WARE J, Allen JM, Boughton CK, Wilinska ME, et al
    Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:209-219.
    >> Share

  92. VIDENOVIC A, Babu S, Zhao B, Reda HM, et al
    Case 1-2022: A 67-Year-Old Man with Motor Neuron Disease and Odd Behaviors during Sleep.
    N Engl J Med. 2022;386:173-180.
    >> Share

  93. PAVORD S, Lester W, Hunt BJ
    Clinical Features of VITT. Reply.
    N Engl J Med. 2022;386.
    >> Share

  94. CHITI A
    Clinical Features of VITT.
    N Engl J Med. 2022;386.
    >> Share

    December 2021
  95. LACY J, Pavord S, Brown KE
    VITT and Second Doses of Covid-19 Vaccine.
    N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMc2118507.
    >> Share

  96. DILLY B, Bomahou C
    Tongue Necrosis in Giant-Cell Arteritis.
    N Engl J Med. 2021;385:2377.
    >> Share

  97. BRADBURY CA, Hill Q, Greenwood R
    Mycophenolate Mofetil for Immune Thrombocytopenia. Reply.
    N Engl J Med. 2021;385:2201-2202.
    >> Share

  98. VAN DIJK WEM, Schutgens REG
    Mycophenolate Mofetil for Immune Thrombocytopenia.
    N Engl J Med. 2021;385:2201.
    >> Share

  99. GHANIMA W, Zaja F, Michel M
    Mycophenolate Mofetil for Immune Thrombocytopenia.
    N Engl J Med. 2021;385:2200-2201.
    >> Share

  100. CHEN S, Dong C, Wei JC
    Mycophenolate Mofetil for Immune Thrombocytopenia.
    N Engl J Med. 2021;385:2200.
    >> Share

    November 2021
  101. O'CONNELL J, Nathan DM, O'Brien T, O'Keeffe DT, et al
    Treatment of Diabetes - To Pump or Not to Pump.
    N Engl J Med. 2021;385:2092-2095.
    >> Share

  102. MANDL A, Burbelo PD, Di Pasquale G, Tay YS, et al
    Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor.
    N Engl J Med. 2021;385:1974-1980.
    >> Share

  103. BJORNSTAD P, Drews K, Zeitler PS
    Long-Term Complications in Youth-Onset Type 2 Diabetes. Reply.
    N Engl J Med. 2021;385:2016.
    >> Share

  104. NELSON RG, Hanson RL, Knowler WC
    Long-Term Complications in Youth-Onset Type 2 Diabetes.
    N Engl J Med. 2021;385:2015.
    >> Share

  105. YANG W, Wang C
    Long-Term Complications in Youth-Onset Type 2 Diabetes.
    N Engl J Med. 2021;385:2014-2015.
    >> Share

  106. MOUGIAKAKOS D, Kronke G, Schett G
    More on CD19-CAR T Cells in Systemic Lupus Erythematosus. Reply.
    N Engl J Med. 2021;385:e67.
    >> Share

  107. KONIG MF, Paul S
    More on CD19-CAR T Cells in Systemic Lupus Erythematosus.
    N Engl J Med. 2021;385:e67.
    >> Share

  108. SCHONBORN L, Thiele T, Kaderali L, Greinacher A, et al
    Decline in Pathogenic Antibodies over Time in VITT.
    N Engl J Med. 2021;385:1815-1816.
    >> Share

    October 2021
  109. BERENTSEN S, Barcellini W
    Autoimmune Hemolytic Anemias.
    N Engl J Med. 2021;385:1407-1419.
    >> Share

    September 2021
  110. MATTHIESEN MI, Shailam R, Rothermel H
    Case 29-2021: A 12-Month-Old Boy with Fever and Developmental Regression.
    N Engl J Med. 2021;385:1220-1229.
    >> Share

  111. TSUI JC, Onishi S
    Symblepharon in Linear IgA Bullous Dermatosis.
    N Engl J Med. 2021;385:1219.
    >> Share

  112. WERTH VP, Joly P, Chen DM
    Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris. Reply.
    N Engl J Med. 2021;385:1056.
    >> Share

  113. HOPKINS ZH, Wu BC, Nousari CH
    Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris.
    N Engl J Med. 2021;385:1055-1056.
    >> Share

  114. BOLTON-MAGGS PHB, George JN
    Immune Thrombocytopenia Treatment.
    N Engl J Med. 2021;385:948-950.
    >> Share

  115. BRADBURY CA, Pell J, Hill Q, Bagot C, et al
    Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia.
    N Engl J Med. 2021;385:885-895.
    >> Share

    August 2021
  116. PAVORD S, Scully M, Hunt BJ, Lester W, et al
    Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109908.
    >> Share

  117. GOYAL RK
    Gastric Emptying Abnormalities in Diabetes Mellitus. Reply.
    N Engl J Med. 2021;385:576.
    >> Share

  118. AKTURK HK, Shah VN
    Gastric Emptying Abnormalities in Diabetes Mellitus.
    N Engl J Med. 2021;385:575-576.
    >> Share

  119. MOUGIAKAKOS D, Kronke G, Volkl S, Kretschmann S, et al
    CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.
    N Engl J Med. 2021;385:567-569.
    >> Share

    July 2021
  120. SMIBERT OC, Catalano OA, Goodarzi K, Roberts MB, et al
    Case 23-2021: A 41-Year-Old Woman with Bloody Stools and Thrombocytopenia.
    N Engl J Med. 2021;385:451-460.
    >> Share

  121. KRATKA A, Yozamp N, Vaidya A, Marqusee E, et al
    A Periodic Problem.
    N Engl J Med. 2021;385:e17.
    >> Share

  122. AVELAR RODRIGUEZ D, Orkin J
    An Icteric Tongue.
    N Engl J Med. 2021;385:e16.
    >> Share

  123. MORAN-THOMAS A
    One Hundred Years of Insulin for Some.
    N Engl J Med. 2021;385:293-295.
    >> Share

  124. GOGLIN SE, Margaretten ME
    Malar Rash.
    N Engl J Med. 2021;385:164.
    >> Share

  125. PATRIQUIN CJ, Laroche V, Selby R, Pendergrast J, et al
    Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2109465.
    >> Share

    June 2021
  126. O'CONNELL KA, LaChance AH
    Dermatomyositis.
    N Engl J Med. 2021;384:2437.
    >> Share

  127. SEEKER P, Osswald S
    Tongue Discoloration.
    N Engl J Med. 2021;384:e102.
    >> Share

  128. WERTH VP, Joly P, Mimouni D, Maverakis E, et al
    Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
    N Engl J Med. 2021;384:2295-2305.
    >> Share

    May 2021
  129. JAYNE DRW, Merkel PA, Bekker P
    Avacopan for the Treatment of ANCA-Associated Vasculitis. Reply.
    N Engl J Med. 2021;384:e81.
    >> Share

  130. MATSUO Y, Miyabe Y
    Avacopan for the Treatment of ANCA-Associated Vasculitis.
    N Engl J Med. 2021;384:e81.
    >> Share

  131. CHANDWAR K
    Avacopan for the Treatment of ANCA-Associated Vasculitis.
    N Engl J Med. 2021;384:e81.
    >> Share

  132. BLANCO-DOMINGUEZ R, Sanchez-Diaz R, de la Fuente H, Jimenez-Borreguero LJ, et al
    A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
    N Engl J Med. 2021;384:2014-2027.
    >> Share

  133. GIBBONS MD, Mendoza DP, Waheed A, Barshak MB, et al
    Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia.
    N Engl J Med. 2021;384:1849-1857.
    >> Share

  134. FRALICK M, Sarma S
    Thyrotoxic Periodic Paralysis.
    N Engl J Med. 2021;384:e71.
    >> Share

  135. MOHAMED F, Raal FJ
    Hyperpigmentation from Addison's Disease.
    N Engl J Med. 2021;384:1752.
    >> Share

    April 2021
  136. KOREN D, Sparger KA, Shailam R, Sadow PM, et al
    Case 13-2021: A Newborn Girl with a Neck Mass.
    N Engl J Med. 2021;384:1647-1655.
    >> Share

  137. GREINACHER A, Thiele T, Warkentin TE, Weisser K, et al
    Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104840.
    >> Share

  138. SCHULTZ NH, Sorvoll IH, Michelsen AE, Munthe LA, et al
    Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104882.
    >> Share

  139. ROTH A, Barcellini W, D'Sa S, Miyakawa Y, et al
    Sutimlimab in Cold Agglutinin Disease.
    N Engl J Med. 2021;384:1323-1334.
    >> Share

  140. ZONOZI R, Niles JL
    Sunken Nose.
    N Engl J Med. 2021;384:e52.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016